General Information
Conference Tracks and Topics
The Strategic Questions Shaping the Future of Microbiota Medicine
1. Functional Microbiome and Host Regulation
Host microbiota communication
Immune regulation and inflammation
Gut barrier and mucosal biology
Microbial metabolites and signaling
Microbiota organ communication axes
Skin microbiota and systemic health
Environmental exposome and microbiota
2. Causality, Prediction and Systems Biology
Moving from correlation to causality
Human causality models
Longitudinal microbiome dynamics
Functional microbiomics
Multiomics and disease stratification
AI and systems microbiology
Responders and non responders
Predictive microbiome signatures
3. Microbial Metabolites and Metabolomics
Short chain fatty acids
Bile acids and tryptophan metabolites
Postbiotics and microbial signaling molecules
Diet microbiota metabolite interactions
Metabolite based biomarkers
Metabolomics for clinical translation
Microbial metabolites and systemic health
4. Microbiota Based Therapies and Therapeutic Platforms
Live biotherapeutics
Engineered microbes
Fecal microbiota transplantation
Microbiome derived therapeutics
Phage therapy and ecosystem modulation
Microbiota targeted interventions
Regulatory and clinical development pathways
5. Microbiome Diagnostics, Devices and Biomarkers
Microbiome based diagnostics
Early disease prediction
Patient stratification
Digital microbiome tools
Medical devices and microbiome monitoring
At home testing and longitudinal tracking
Biomarkers for prevention and precision medicine
6. Microbiota, Longevity and Healthy Aging
Microbiota and biological aging
Gut brain axis and cognitive aging
Gut cardiovascular axis
Microbiota and metabolic resilience
Sarcopenia and skeletal muscle health
Early life microbiome and late life disease
Microbiota and inflammaging
Nutrition strategies for healthy longevity
7. Microbiota Innovation, Industry and Translation
Startup and biotech innovation
Industrial microbiome platforms
Precision nutrition technologies
Skin microbiome and cosmetic innovation
AI driven microbiome platforms
Investors and strategic partnerships
Commercialization and market access
Academic industry collaboration
8. Virome, Phages, Mycobiome and Emerging Ecosystems
Human virome
Bacteriophages and microbiome control
Phage therapy beyond infection
Mycobiome and fungal interactions
Microbiota derived extracellular vesicles
Cross kingdom interactions
Emerging microbial ecosystems
9. Microbiota Across Organs and Conditions
Gut microbiota and gastrointestinal diseases
Microbiota and metabolism
Microbiota and cardiovascular disease
Microbiota and CNS disorders
Microbiota and fertility
Microbiota and cancer
Microbiota and immune mediated diseases
Animal microbiota and translational models
10. Outstanding Innovation Symposium
Microbiota Moonshot
Next generation microbiome therapeutics
AI and predictive microbiome medicine
Devices and continuous monitoring
Microbial biomarkers and diagnostics
Longevity technologies
Selected startup presentations
Industry and investors round table
Concluding remarks of the 4th World Congress on Targeting Microbiota
The 4th World Congress on Targeting Microbiota which was held at Pasteur Institute on October 17-19 was a huge success. More than 300 attendees participated during this 3-day congress. Academics and industrials from more than 37 countries gathered to discuss the recent scientific advances on microbiota and all related researches such as phage therapy, fecal microbiota transplantation, and also about microbiota analysis and the challenge of the interpretation of the data.
Final Agenda of Targeting Microbiota 2016
The scientific committee announces the publication of the final agenda of Targeting Microbiota 2016 with the list of short oral presentations accepted.
To access to the program, please click here.
Targeting Microbiota Dinner will be organized on October 18 in the Sofitel Paris Le Faubourg
Targeting Microbiota dinner is organized on Tuesday, October 18 in the Sofitel Paris Le Faubourg, in the center of Paris.
